CLINICAL_TRIALS trial_result · 2021-06-30

Clinical Trial Update: S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma [Phase 2]

Phase 2 trial evaluating S1001 PET-directed therapy for limited-stage diffuse large B-cell lymphoma has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2021-06-30